News

2 nouveaux établissements équipés avec CeGInaDis

Fédialis Médica a le plaisir de vous informer que les hôpitaux de la Pitié-Salpêtrière à Paris, ainsi que le ​CHU de ​Fort de France en Martinique utilisent notre logiciel CeGInaDis (version CeGIDD du logiciel NADIS) pour leurs activités de routine CeGIDD.

Read more

Annonce d’un nouveau partenariat AFRAVIH – Fédialis Médica

Fédialis Médica a le plaisir de vous informer de la signature d’un partenariat avec l’AFRAVIH (www.afravih.org/) dans le but de tester l’utilisation du dossier médical informatisé NADIS pour le suivi et la prise en charge de patients vivant avec une pathologie chronique (VIH, hépatite, t…

Read more

SEQHEPB V6 – The Largest HBV Interpretation System & Database

ABL is pleased to announce the official release of its SeqHepB v6 interpretation system & database. Dedicated to the management of Viral Hepatitis B (HBV) sequencing data, the software can handle Capillary Electrophoresis or Next Generation Sequencing data, performs genotyping and mutation detec…

Read more

Studies on DeepChek®-HCV Assays presented at the EASL 2017

“Evaluation of a sequence-based method for hepatitis C genotyping (DeepChek® SingleRound PCR and NS5B/5’UTR sequencing) and comparison with VERSANT HCV Genotype 2.0 assay (InnoLiPA)” – Greet J. Boland et al. – EASL 2017 – See poster “Retreatment with Direct…

Read more

New patent issued in Hong Kong around HBV resistance announced!

Advanced Biological Laboratories has been granted additional patents in Hong Kong (HK1121187) to further protect its intellectual property and reinforce the already existing core patent entitled ” Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications th…

Read more

ABL Welcomes You at the EASL in Amsterdam (April 19th – 22nd 2017)

Our team will provide information on our portfolio: Laboratories, virologists and microbiologists: DeepChek® Assays (Genotyping & Drug Resistance) UltraGene® Assays (Viral Load Detection) DeepChek®, SeqHepB® (Software systems for Sanger or NGS sequencing data management) Application: HBV, HCV… C…

Read more

Latest updates on ABL’s HIV Assays Portfolio

ABL is delighted to announce the outcomes of a National Quality Control Study performed on the DeepChek® HIV Assays (RT/PR and INTEGRASE) on a panel human plasma samples collected in 2015 in 56 different labs in France. The overall agreement in the detection of HIV virus mutations exceeded 99% compa…

Read more

Technogenetics to Offer ABL’s Genotyping Products in Italy

Advanced Biological Laboratories (ABL) S.A. and Technogenetics (TGX) today announced that they entered into an exclusive distributor agreement of the DeepChek® SingleRound Assay and software product lines in Italy. The DeepChek® SingleRound Assay product line combines target-specific PCR reagents wi…

Read more
#